Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach

IF 7.9 1区医学 Q1 IMMUNOLOGY

Journal of autoimmunity Pub Date : 2025-04-08 DOI:10.1016/j.jaut.2025.103416

Annalisa Marino , Irene Genovali , Luca Navarini , Elena Pontarini , Marta Vomero , Damiano Currado , Andrea Pilato , Letizia Pia Di Corcia , Michele Bombardieri , Roberto Giacomelli , Onorina Berardicurti

{"title":"Clinical targeted treatment in Sjogren's disease: A systematic literature review for an evidence-based medicine approach","authors":"Annalisa Marino , Irene Genovali , Luca Navarini , Elena Pontarini , Marta Vomero , Damiano Currado , Andrea Pilato , Letizia Pia Di Corcia , Michele Bombardieri , Roberto Giacomelli , Onorina Berardicurti","doi":"10.1016/j.jaut.2025.103416","DOIUrl":null,"url":null,"abstract":"<div><div>Sjögren's disease is a systemic autoimmune disease that primarily affects the exocrine glands, causing the main symptoms of xerostomia and xerophthalmia. In about half of the patients, it also causes systemic symptoms, which can potentially involve any organ or system. To date, the management of these patients is particularly complex due to the lack of recognized and approved therapies for the disease, except for medications used as symptomatic treatment for dryness. Due to the limited evidence available, therapeutic decisions in daily practice are frequently based on a combination of expert opinions and personal experience, which can vary significantly between clinicians. On these bases, we performed as systematic literature review critically analyzing the results of the previous trials, unpacking the single domains of ESSDAI, to evaluate if there are treatments significantly effective in some manifestations of the disease.</div></div>","PeriodicalId":15245,"journal":{"name":"Journal of autoimmunity","volume":"153 ","pages":"Article 103416"},"PeriodicalIF":7.9000,"publicationDate":"2025-04-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of autoimmunity","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0896841125000617","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"IMMUNOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Sjögren's disease is a systemic autoimmune disease that primarily affects the exocrine glands, causing the main symptoms of xerostomia and xerophthalmia. In about half of the patients, it also causes systemic symptoms, which can potentially involve any organ or system. To date, the management of these patients is particularly complex due to the lack of recognized and approved therapies for the disease, except for medications used as symptomatic treatment for dryness. Due to the limited evidence available, therapeutic decisions in daily practice are frequently based on a combination of expert opinions and personal experience, which can vary significantly between clinicians. On these bases, we performed as systematic literature review critically analyzing the results of the previous trials, unpacking the single domains of ESSDAI, to evaluate if there are treatments significantly effective in some manifestations of the disease.

查看原文本刊更多论文

Sjogren病的临床靶向治疗：循证医学方法的系统文献综述

Sjögren的疾病是一种系统性自身免疫性疾病，主要影响外分泌腺，引起口干和干眼症的主要症状。在大约一半的患者中，它还会引起全身性症状，可能涉及任何器官或系统。迄今为止，由于缺乏公认和批准的治疗方法，除了用于干燥症状治疗的药物外，这些患者的管理特别复杂。由于可获得的证据有限，日常实践中的治疗决策经常基于专家意见和个人经验的结合，这在临床医生之间可能会有很大差异。在此基础上，我们进行了系统的文献综述，批判性地分析了以前的试验结果，揭示了ESSDAI的单一域，以评估是否存在对该疾病的某些表现显着有效的治疗方法。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Journal of autoimmunity 医学-免疫学

CiteScore

27.90

自引率

1.60%

发文量

117

审稿时长

17 days

期刊介绍： The Journal of Autoimmunity serves as the primary publication for research on various facets of autoimmunity. These include topics such as the mechanism of self-recognition, regulation of autoimmune responses, experimental autoimmune diseases, diagnostic tests for autoantibodies, as well as the epidemiology, pathophysiology, and treatment of autoimmune diseases. While the journal covers a wide range of subjects, it emphasizes papers exploring the genetic, molecular biology, and cellular aspects of the field. The Journal of Translational Autoimmunity, on the other hand, is a subsidiary journal of the Journal of Autoimmunity. It focuses specifically on translating scientific discoveries in autoimmunity into clinical applications and practical solutions. By highlighting research that bridges the gap between basic science and clinical practice, the Journal of Translational Autoimmunity aims to advance the understanding and treatment of autoimmune diseases.